BIONIK LABORATORIES CORP. CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • September 11th, 2017 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This Note is a convertible promissory note referred to in that certain Subscription Agreement dated as of the date hereof, or series of like subscription agreements (the “Subscription Agreement”), among the Company and the subscribers named therein, pursuant to which the Company is seeking to borrow up to $2,000,000.
EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the 1st day of September 2017. BETWEEN: BIONIK LABORATORIES INC., a corporation incorporated under the laws of Canada (hereinafter referred to as the “Company”) - and -Employment Agreement • September 11th, 2017 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Ontario
and BIONIK LABORATORIES CORP., a corporation incorporated under the laws of the state of Delaware (hereinafter referred to as “Bionik U.S.”)
AGREEMENT BETWEEN: BIONIK LABORATORIES ("Bionik") - and - PETER BLOCH ("Mr. Bloch")Severance Agreement • September 11th, 2017 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies
EQUITY COMPENSATION AGREEMENTEquity Compensation Agreement • September 11th, 2017 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
THIS EQUITY COMPENSATION AGREEMENT (this “Agreement”) made as of the 1st day of September 2017, between BIONIK LABORATORIES CORP, a corporation incorporated under the laws of the state of Delaware (hereinafter referred to as the “Issuer“) and 4A Consulting & Engineering, a consulting company located 18 Chemin de la Vierge Noire 38700 La Tronche, France (hereinafter referred to as the “Recipient“, the Issuer and the Recipient being hereinafter referred to as the “Parties”).
EQUITY COMPENSATION AGREEMENTEquity Compensation Agreement • September 11th, 2017 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies
THIS EQUITY COMPENSATION AGREEMENT (this "Agreement") made as of the 1st day of September 2017, between BIONIK LABORATORIES CORP, a corporation incorporated under the laws of the state of Delaware (hereinafter referred to as the "Issuer") and Eric Dusseux, an individual resident in France (hereinafter referred to as the "Employee");
